In November 2025, the Department of Veterans Affairs entered into an agreement with Baylor Genetics to provide nationwide pharmacogenomic (PGx) and germline genetic testing services across the VA healthcare system. The partnership allowed VA providers to use advanced precision diagnostics to tailor treatment plans for conditions like post-traumatic stress disorder (PTSD) and depression, minimize side…